Sarcoma  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
TAILOR, NCT01228734: A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients

Checkmark CRC
Jul 2016 - Jul 2016: CRC
Checkmark In patients with RAS wild-type mCRC
Jul 2016 - Jul 2016: In patients with RAS wild-type mCRC
Checkmark In CRC
More
Completed
3
553
RoW
Cetuximab, Erbitux, C225, Oxaliplatin, Folinic Acid, 5Fluorouracil
Merck KGaA, Darmstadt, Germany
Metastatic Colorectal Cancer
01/16
01/18

Download Options